参考文献/References:
[1] LANZAVECCHIA A,SALLUSTO F.Regulation of T cell immunity by dendritic cells[J].Cell,2001,106(3):263-266.
[2] MILDNER A,JUNG S.Development and function of dendritic cell subsets[J].Immunity,2014,40(5):642-656.
[3] LAVOIE H,THERRIEN M.Regulation of RAF protein kinases in ERK signalling[J].Nat Rev Mol Cell Biol,2015,16(5):281-298.
[4] 王东军,董虹廷.人脑神经胶质瘤组织中细胞外信号调节激酶和磷脂酰肌醇 3激酶的表达及其临床意义[J].新乡医学院学报,2014,31(12):978-982.
[5] MCCUBREY J A,STEELMAN L S,CHAPPELL W H,et al.Roles of the Raf/MEK/ERK pathway in cell growth,malignant transformation and drug resistance[J].Biochim Biophys Acta,2007,1773(8):1263-1284.
[6] MA L,CHEN Z,ERDJUMENT-BROMAGE H,et al.Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis[J].Cell,2005,121(2):179-193.
[7] KINDRACHUK J,ORK B,HART B J,et al.Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis[J].Antimicrob Agents Chemother,2015,59(2):1088-1099.
[8] SHI F,LEN Y,GONG Y,et al.Ribavirin inhibits the activity of mTOR/eIF4E,ERK/Mnk1/eIF4E signaling pathway and synergizes with tyrosine kinase inhibitor imatinib to impair Bcr-Abl mediated proliferation and apoptosis in Ph+leukemia[J].PLoS One,2015,10(8):e0136746.
[9] PARK H,KIM Y,SUL J W,et al.Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant prostate cancer[J].Prostate,2015,75(15):1747-1759.
[10] SCHEFFLER J M,SPARBER F,TRIPP C H,et al.LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signalling[J].Nat Commun,2014,5:5138.
[11] WU W,WANG W,WANG Y,et al.IL-37b suppresses T cell priming by modulating dendritic cell maturation and cytokine production via dampening ERK/NF-kappaB/S6K signalings[J].Acta Biochim Biophys Sin(Shanghai),2015,47(8):597-603.
[12] WU P K,PARK J I.MEK1/2 inhibitors:molecular activity and resistance mechanisms[J].Semin Oncol,2015,42(6):849-862.
[13] 徐岚.大蒜素促进人子宫内膜癌细胞株HEC-1细胞凋亡的细胞外信号调节激酶信号通路研究[J].新乡医学院学报,2016,33(1):20-22.
[14] ZHAO B X,SUN Y B,WANG S Q,et al.Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-kappaB and MAPK/ERK mediated YB-1 activity in A2780/T cells[J].PLoS One,2013,8(8):e71071.
[15] ZHAO X,LIU L,LIU D,et al.Progesterone enhances immunoregulatory activity of human mesenchymal stem cells via PGE2 and IL-6[J].Am J Reprod Immunol,2012,68(4):290-300.
[16] BANCHEREAU J,COHN F,INABA K,et al.Remembering ralph steinman[J].J Exp Med,2011,208(12):2343-2347.
[17] HONG J,GU X D,XIANG J B,et al.Recipient dendritic cells modified by RNA interference targeting CD80 and CD86 elicit T cell hyporesponsiveness via enhanced T cell apoptosis[J].Chin Med J(Engl),2013,126(11):2139-2144.
[18] BAK S P,BARNKOB M S,BAI A,et al.Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells[J].J Immunol,2012,189(4):1708-1716.
[19] JIGA L P,BAUER T M,CHUANG J J,et al.Generation of tolerogenic dendritic cells by treatment with mitomycin C:inhibition of allogeneic T-cell response is mediated by downregulation of ICAM-1,CD80,and CD86[J].Transplantation,2004,77(11):1761-1764.
[20] GUTCHER I,BECHER B.APC-derived cytokines and T cell polarization in autoimmune inflammation[J].J Clin Invest,2007,117(5):1119-1127.
[21] BETTELLI E,CARRIER Y,GAO W,et al.Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells[J].Nature,2006,441(7090):235-238.
[22] ARMBRUSTER N S,RICHARDSON J R,SCHREINER J,et al.PSM peptides of staphylococcus aureus activate the p38-CREB pathway in dendritic cells,thereby modulating cytokine production and T cell priming[J].J Immunol,2016,196(3):1284-1292.
[23] LIU C,SHENG W,FU R,et al.Differential expression of the proteome of myeloid dendritic cells in severe aplastic anemia[J].Cell Immunol,2013,285(1/2):141-148.